Etoposide (VP16-213) in the treatment of advanced nasopharyngeal carcinoma.
Shiu
W C
WC
Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, N.T.
Tsao
S Y
SY
D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005047:Etoposide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy*
D005047:Etoposide